Neonatal dexamethasone treatment exacerbates hypoxic-ischemic brain damage
碩士 === 國立成功大學 === 藥理學研究所 === 100 === The synthetic glucocorticoid dexamethasone (DEX) is frequently used to prevent or lessen the morbidity of chronic lung disease (CLD) by facilitating surfactant synthesis in pulmonary alveolus in premature infants. Typically, high doses of DEX are administered for...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2012
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/46329620347512912800 |